These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 17487822

  • 1. Angiotensin-converting enzyme inhibitors and coronary heart disease prevention.
    Donnelly R, Manning G.
    J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):13-22. PubMed ID: 17487822
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N, Cucherat M, Thuillez C, Durand E, Kadri Z, Steg PG.
    Arch Intern Med; 2006 Apr 10; 166(7):787-96. PubMed ID: 16606817
    [Abstract] [Full Text] [Related]

  • 3. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA, Molnar J, Arora RR.
    Diabetes Obes Metab; 2008 Jan 10; 10(1):41-52. PubMed ID: 18095949
    [Abstract] [Full Text] [Related]

  • 4. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar 10; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 5. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH.
    Can J Cardiol; 2004 Aug 10; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [Abstract] [Full Text] [Related]

  • 6. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML, EUROPA investigators.
    Int J Cardiol; 2007 Sep 14; 121(1):57-61. PubMed ID: 17270296
    [Abstract] [Full Text] [Related]

  • 7. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
    Saha SA, Molnar J, Arora RR.
    J Cardiovasc Pharmacol Ther; 2007 Sep 14; 12(3):192-204. PubMed ID: 17875946
    [Abstract] [Full Text] [Related]

  • 8. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
    Fox K, Ferrari R, Yusuf S, Borer JS.
    Eur Heart J; 2006 Sep 14; 27(18):2154-7. PubMed ID: 16905555
    [Abstract] [Full Text] [Related]

  • 9. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 14; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 10. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C, Ciliberti P, Graziosi M, Riva L.
    Ital Heart J; 2005 Nov 14; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
    van Gilst WH, Warnica JW, Baillot R, Johnstone D, Calciu CD, Block P, Myers MG, Chocron S, Rouleau JL, IMAGINE Investigators.
    Am Heart J; 2006 Jun 14; 151(6):1240-6. PubMed ID: 16781228
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ, Ferrari R, Simoons ML.
    Expert Rev Cardiovasc Ther; 2009 Apr 14; 7(4):345-60. PubMed ID: 19379059
    [Abstract] [Full Text] [Related]

  • 13. Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function.
    Pepine CJ.
    J Am Coll Cardiol; 1996 Apr 14; 27(5):1048-52. PubMed ID: 8609320
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ.
    Med Sci Monit; 2004 Dec 14; 10(12):SR23-8. PubMed ID: 15567997
    [Abstract] [Full Text] [Related]

  • 15. Insight into ACE inhibition in the prevention of cardiac events in stable coronary artery disease: the EUROPA trial.
    Ferrari R, Bertrand ME, Remme WJ, Simoons ML, Deckers JW, Fox KM.
    Expert Rev Cardiovasc Ther; 2007 Nov 14; 5(6):1037-46. PubMed ID: 18035919
    [Abstract] [Full Text] [Related]

  • 16. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S.
    Nat Clin Pract Cardiovasc Med; 2006 Apr 14; 3(4):220-5. PubMed ID: 16568131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C.
    Ital Heart J; 2005 Nov 14; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [Abstract] [Full Text] [Related]

  • 19. The European trial on reduction of cardiac events with perindopril in stable coronary artery disease (EUROPA).
    Fox KM, Henderson JR, Bertrand ME, Ferrari R, Remme WJ, Simoons ML.
    Eur Heart J; 1998 Sep 14; 19 Suppl J():J52-5. PubMed ID: 9796841
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R.
    Expert Rev Cardiovasc Ther; 2005 Jan 14; 3(1):15-29. PubMed ID: 15723572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.